(Q43497161)

24 November 2017

Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women (English)

1 reference

24 November 2017

1 reference

1 reference

A J Tingle

1

1 reference

24 November 2017

L A Mitchell

2

1 reference

24 November 2017

M Grace

3

1 reference

24 November 2017

P Middleton

4

1 reference

24 November 2017

R Mathias

5

1 reference

24 November 2017

L MacWilliam

6

1 reference

24 November 2017

A Chalmers

7

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

24 November 2017

1 reference

24 November 2017

349

1 reference

24 November 2017

9061

1 reference

24 November 2017

1277-1281

1 reference

Post-partum vaccination of rubella-susceptible women.

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Acute Arthritis Complicating Rubella Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Immunologic response, virus excretion, and joint reactions with rubella vaccine. A study of adolescent girls and young women given live attenuated virus vaccine (HPV-77:DE-5).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Joint reactions in children vaccinated against rubella. II. Comparison of three vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

A controlled comparison of joint reactions among women receiving one of two rubella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Prospective Immunological Assessment of Arthritis Induced by Rubella Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Prolonged arthritis, viraemia, hypogammaglobulinaemia, and failed seroconversion following rubella immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Chronic arthritis after rubella vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Joint symptoms following an area-wide rubella immunization campaign--report of a survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Clinical and laboratory studies of live attenuated RA 27/3 and HPV 77-DE rubella virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Is RA27/3 rubella immunization a cause of chronic fatigue?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Rheumatoid arthritis after rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Rubella-virus infection in juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Persistent rubella virus infection associated with chronic arthritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Intermittent arthritis following rubella vaccination. A three-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Prolonged Arthritis in Identical Twins After Rubella Immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Studies on vaccine-induced rubella arthritis. Serologic findings before and after immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Absence of an association between rubella vaccination and arthritis in underimmune postpartum women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2912031-6

7 January 2021

10.1016/S0140-6736(96)12031-6

Identifiers

DOI

1 reference

24 November 2017

1 reference